Brookfield Corporation (BN), the Toronto-headquartered global owner and operator of real assets spanning infrastructure, renewable power, real estate, private equity, and credit, carries a broadly bullish sell-side posture. Across eight individually verified targets reviewed for this analysis, the range runs from $31 to $61, with a calculated mean of about $52.60, rounded to a central target of $53. I also checked comparable names using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent targets and actions include Morgan Stanley maintaining Buy while trimming its target from $59 to $54 (October 2026); Goldman Sachs cutting from $56 to $54 (August 2026); RBC Capital and TD Cowen both reiterating $61; J.P. Morgan at $56; BMO Capital at $51; and Scotiabank at $53. One Sell-rated analyst carries the $31 figure, which sits below the current price. The overall published mean across 11 analysts tracked by S&P Global is approximately $53.75, with a consensus rating of Buy.
The spread between $31 and $61 is wide, so the central target should be read as a midpoint of informed opinion rather than a precise forecast. Analysts generally argue Brookfield's portfolio of hard assets and its ownership stake in its separately listed asset manager are not fully reflected in the current share price, while the cautious view emphasizes valuation and mark-to-market complexity.
With the shares near $38.03, reaching $53 would require an advance of roughly 39% — a substantial move by any standard. The stock trades near the lower end of its 52-week range of $35.61 to $49.57, after a decline of about 21% through much of 2026.
A path toward the target would likely depend on a combination of stronger distributable earnings, improved realizations in private equity and credit, a re-rating of the asset-management stake, and a more supportive backdrop for long-duration and leveraged assets. Brookfield's reported earnings are heavily influenced by mark-to-market and consolidation effects, so headline results can swing materially from quarter to quarter. Its next earnings report is scheduled for November 12, 2026.
Brookfield's franchise breadth is a core support: diversified infrastructure and renewable-power assets tend to generate relatively stable, inflation-linked cash flows, while the insurance and credit businesses have grown. The company retains a substantial economic stake in its separately listed asset manager, Brookfield Asset Management (BAM), which many analysts view as underappreciated within the holding-company structure. Falling long-term interest rates or narrowing credit spreads would typically support asset valuations, while robust exit markets would help crystallize carried interest and realization gains. Analyst revisions, though recently mixed with several small target cuts, remain predominantly Buy-rated.
The principal obstacles are valuation and leverage. The trailing P/E (price-to-earnings) ratio is elevated — in the high-60s to low-70s — reflecting earnings that are compressed by mark-to-market adjustments, while a beta near 1.8 means the stock has historically fallen harder than the market in risk-off periods. A meaningful portion of Brookfield's debt sits at the asset level in non-recourse structures, but refinancing remains sensitive to long-term rates and credit spreads. The office and retail real estate books remain the least liquid segments, and a prolonged slowdown in transaction and exit markets would delay realization income. The lone $31 target illustrates that a genuinely cautious case exists.
The shares sit near a 52-week low of $35.61, which represents the clearest near-term support level. On the upside, prior congestion between roughly $42 and $45, followed by the 52-week high of $49.57, marks key resistance zones the stock would need to reclaim before a move toward $53 becomes technically plausible. The long-term trend remains under pressure after the 2026 decline, with the shares trading below longer-term moving averages, so any sustained advance would require a change in trend structure rather than a brief bounce.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms differ. Investors weighing the $53 target should watch the November 12, 2026 earnings release and guidance, particularly distributable earnings, fee-related earnings at the asset manager, and any commentary on realizations and fundraising. Beyond earnings, the most relevant items are interest-rate decisions from the Federal Reserve, credit-spread movements, transaction activity in private equity and credit, insurance-segment performance, and any changes to analyst targets, which have been drifting modestly lower in some cases.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. I find this tool helpful for flagging momentum shifts in names like Brookfield without replacing deeper fundamental work. It complements the analyst targets by highlighting when market structure starts to align with or diverge from the broader consensus view.
Can Brookfield Corporation (BN) stock reach $53? The central target — the mean of eight verified analyst targets, with the full range spanning $31 to $61 — implies a roughly 39% move from the current price near $38, which is substantial. The case rests on Brookfield's diversified real-assets franchise, its stake in the listed asset manager, and a predominantly Buy-rated analyst base. The counterarguments are equally real: elevated headline valuation multiples, mark-to-market earnings volatility, interest-rate and credit sensitivity, and a technical picture still weighed down by the 2026 decline. The wide analyst range underscores that this is a genuinely contested stock, and the answer will hinge on earnings execution, transaction markets, and the interest-rate environment rather than any single data point. No outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BN advanced for three days, in 225 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
BN moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
The Aroon Indicator entered an Uptrend today. In 149 of 270 cases where BN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The 10-day RSI Indicator for BN moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 23 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 56%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BN as a result. In 44 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.
The Moving Average Convergence Divergence Histogram (MACD) for BN turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 27 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
BN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. BN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.174) is normal, around the industry mean (2.423). BN has a moderately high P/E Ratio (73.893) as compared to the industry average of (8.341). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.318). Dividend Yield (0.007) settles around the average of (0.274) among similar stocks. P/S Ratio (1.135) is also within normal values, averaging (15.906).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an alternative asset manager which owns, manages and operates real estate, financial and power generation related businesses
Industry InvestmentManagers